Dan Adams

Dan Adams has a diverse work experience in the field of biology and research. Dan is currently the Director - Head of In Vitro Biology & Platform at Montai Health, where they started in April 2023. Prior to this role, they worked at Skyhawk Therapeutics from January 2020 to April 2023, first as a Principal Scientist & Group Leader and then as a Senior Principal Scientist & Group Leader. From 2017 to 2019, they were a Scientist at Amgen. Before that, they joined Heprotech as a Scientist in October 2014 and played a key role in the company's scientific research and development efforts. Dan also worked as a Postdoctoral Research Associate at Boston College in 2014 and as a Graduate Research Assistant at the University of Colorado at Boulder from 2010 to 2013. Their earliest role was as a Research Assistant at the University of Colorado Boulder from 2008 to 2010, where they focused on the dynamics of splicing snRNP assembly and catalysis using C. elegans as a model. Through their various roles, Dan has gained extensive experience in target validation, assay development, screening, hit-to-lead optimization, preclinical studies, and research in the field of biology and neuroscience.

Dan Adams attended Clark University from 2003 to 2007, where they obtained a Bachelor of Arts (B.A.) in Biochemistry and Molecular Biology. Dan then pursued a Doctor of Philosophy (Ph.D.) degree at the University of Colorado Boulder from 2007 to 2013, specializing in Cell/Cellular and Molecular Biology.